To Order: patrick@cotinis.com
CD152 |
|||
MO152A(V100) | ImmunoStep | 100 ug | EUR 60 |
CD152 |
|||
MO152A(V25) | ImmunoStep | 25 ug | EUR 60 |
CD152 |
|||
MO152B(V100) | ImmunoStep | 100 ug | EUR 60 |
CD152 |
|||
MO152B(V25) | ImmunoStep | 25 ug | EUR 60 |
CD152 |
|||
MO152CFB(V100) | ImmunoStep | 100 ug | EUR 60 |
CD152 |
|||
MO152CFB(V25) | ImmunoStep | 25 ug | EUR 60 |
CD152 |
|||
MO152F(V100) | ImmunoStep | 100 ug | EUR 60 |
CD152 |
|||
MO152F(V25) | ImmunoStep | 25 ug | EUR 60 |
CD152 |
|||
MO152F(V500) | ImmunoStep | 500 ug | EUR 60 |
CD152 |
|||
MO152PE(V100) | ImmunoStep | 100 ug | EUR 60 |
CD152 |
|||
MO152PE(V25) | ImmunoStep | 25 ug | EUR 60 |
CD152 |
|||
MO152PP(V100) | ImmunoStep | 100 ug | EUR 60 |
CD152 |
|||
MO152PP(V25) | ImmunoStep | 25 ug | EUR 60 |
CD152 |
|||
MO152PP5.5(V100) | ImmunoStep | 100 ug | EUR 60 |
CD152 |
|||
MO152PP5.5(V25) | ImmunoStep | 25 ug | EUR 60 |
CD152 |
|||
MO152PU(V100) | ImmunoStep | 100 ug | EUR 60 |
CD152 |
|||
MO152PU(V500) | ImmunoStep | 500 ug | EUR 60 |
CD152 antibody (PE) |
|||
61R-1314 | Fitzgerald | 100 ug | EUR 424.8 |
Description: Mouse monoclonal CD152 antibody (PE) |
CD152 antibody (biotin) |
|||
61R-CD152aMSBT | Fitzgerald | 500 ug | EUR 535.2 |
Description: Hamster monoclonal CD152 antibody (biotin) |
CD152 antibody (FITC) |
|||
61R-CD152aMSFT | Fitzgerald | 500 ug | EUR 548.4 |
Description: Hamster monoclonal CD152 antibody (FITC) |
CD152 antibody (PE) |
|||
61R-CD152aMSPE | Fitzgerald | 100 ug | EUR 360 |
Description: Hamster monoclonal CD152 antibody (PE) |
Anti-CD152 Antibody |
|||
A1388-100 | Biovision | EUR 444 |
CD152 Antibody (FITC) |
|||
abx133968-100Assays | Abbexa | 100 Assays | EUR 526.8 |
CD152 Antibody (FITC) |
|||
abx133968-50Assays | Abbexa | 50 Assays | EUR 410.4 |
CD152 Antibody (Biotin) |
|||
20-abx200697 | Abbexa |
|
|
CD152 Antibody (FITC) |
|||
20-abx200699 | Abbexa |
|
|
Anti-CD152 Antibody |
|||
A00020 | BosterBio | 100ul | EUR 476.4 |
Description: Rabbit Polyclonal Antibody for CD152 Antibody (CTLA4) detection.tested for IHC in Human. |
Anti-CD152 antibody |
|||
STJ98747 | St John's Laboratory | 200 µl | EUR 236.4 |
Description: Rabbit polyclonal to CD152. |
Anti-CD152 antibody |
|||
STJ16100529 | St John's Laboratory | 200 µg | EUR 1023.6 |
CD152 antibody (Azide Free) |
|||
10R-CD152aMSP | Fitzgerald | 500 ug | EUR 548.4 |
Description: Hamster monoclonal CD152 antibody (Azide Free) |
CD152 antibody (Azide Free) |
|||
10R-CD152bMSP | Fitzgerald | 500 ug | EUR 548.4 |
Description: Hamster monoclonal CD152 antibody (Azide Free) |
CD152 (CTLA-4) Antibody |
|||
abx021366-02mg | Abbexa | 0.2 mg | EUR 1220.4 |
CTLA-4 Antibody / CD152 |
|||
R32809 | NSJ Bioreagents | 100 ug | EUR 419 |
CTLA-4 Antibody / CD152 |
|||
RQ6465 | NSJ Bioreagents | 100ug | EUR 419 |
Description: CTLA-4 (Cytotoxic T-Lymphocyte Antigen 4), also known as CD152, is a protein receptor that down regulates the immune system. It is a member of the immunoglobulin superfamily, which is expressed on the surface of Helper T cells and transmits an inhibitory signal to T cells. CTLA4 is similar to the T-cell co-stimulatory protein, CD28, and both molecules bind to CD80 and CD86, also called B7-1 and B7-2 respectively, on antigen-presenting cells. CTLA4 transmits an inhibitory signal to T cells, whereas CD28 transmits a stimulatory signal. Blockade of CTLA4 expression in vitro augmented HIV-specific CD4-positive T-cell function. |
CTLA-4 Antibody / CD152 |
|||
V7700-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: This CTLA4 antibody is specific to the soluble form of the protein. CTLA4 (CD152) is a cell surface receptor that behaves as a negative regulator of the proliferation and the effector function of T cells. It contains a V domain, a transmembrane domain, and a cytoplasmic tail. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. The membrane-bound isoform functions as a homodimer interconnected by a disulfide bond, while the soluble isoform functions as a monomer. Mutations in this gene have been associated with insulin-dependent diabetes mellitus, Graves disease, Hashimoto thyroiditis, celiac disease, systemic lupus erythematosus, thyroid-associated orbitopathy, and other autoimmune diseases.The novel finding that CTLA-4 molecule is expressed and functional on human tumor cells opens up the possibility of antitumor therapeutic intervention based on targeting this molecule. |
CTLA-4 Antibody / CD152 |
|||
V7700-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
Description: This CTLA4 antibody is specific to the soluble form of the protein. CTLA4 (CD152) is a cell surface receptor that behaves as a negative regulator of the proliferation and the effector function of T cells. It contains a V domain, a transmembrane domain, and a cytoplasmic tail. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. The membrane-bound isoform functions as a homodimer interconnected by a disulfide bond, while the soluble isoform functions as a monomer. Mutations in this gene have been associated with insulin-dependent diabetes mellitus, Graves disease, Hashimoto thyroiditis, celiac disease, systemic lupus erythematosus, thyroid-associated orbitopathy, and other autoimmune diseases.The novel finding that CTLA-4 molecule is expressed and functional on human tumor cells opens up the possibility of antitumor therapeutic intervention based on targeting this molecule. |
CTLA-4 Antibody / CD152 |
|||
V7700SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: This CTLA4 antibody is specific to the soluble form of the protein. CTLA4 (CD152) is a cell surface receptor that behaves as a negative regulator of the proliferation and the effector function of T cells. It contains a V domain, a transmembrane domain, and a cytoplasmic tail. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. The membrane-bound isoform functions as a homodimer interconnected by a disulfide bond, while the soluble isoform functions as a monomer. Mutations in this gene have been associated with insulin-dependent diabetes mellitus, Graves disease, Hashimoto thyroiditis, celiac disease, systemic lupus erythematosus, thyroid-associated orbitopathy, and other autoimmune diseases.The novel finding that CTLA-4 molecule is expressed and functional on human tumor cells opens up the possibility of antitumor therapeutic intervention based on targeting this molecule. |
CTLA-4 Antibody / CD152 |
|||
RQ5483 | NSJ Bioreagents | 100 ul | EUR 419 |
Anti-CTLA4 (CD152) Monoclonal Antibody |
|||
M00020 | BosterBio | 100ug | EUR 476.4 |
Description: Rabbit Monoclonal CTLA4 (CD152) Antibody. Validated in IF, ICC, WB and tested in Human, Mouse, Rat. |
Hamster Anti CTLA-4 (CD152) Antibody |
|||
20-abx137133 | Abbexa |
|
|
Hamster Anti Mouse Cd152 Monoclonal Antibody |
|||
CABT-47114HM | Creative Diagnostics | 0.1 mg | EUR 546 |
Purified Anti-human CD152 Antibody *BN13* |
|||
11520000 | AAT Bioquest | 100 ug | EUR 164 |
APC Anti-human CD152 Antibody *BN13* |
|||
115201C0 | AAT Bioquest | 25 tests | EUR 179 |
APC Anti-human CD152 Antibody *BN13* |
|||
115201C1 | AAT Bioquest | 100 tests | EUR 505 |
APC Anti-human CD152 Antibody *BN13* |
|||
115201C2 | AAT Bioquest | 500 tests | EUR 1887 |
FITC Anti-human CD152 Antibody *BN13* |
|||
115201H0 | AAT Bioquest | 100 tests | EUR 245 |
FITC Anti-human CD152 Antibody *BN13* |
|||
115201H1 | AAT Bioquest | 500 tests | EUR 918 |
TRITC Anti-human CD152 Antibody *BN13* |
|||
115201I0 | AAT Bioquest | 100 tests | EUR 245 |
TRITC Anti-human CD152 Antibody *BN13* |
|||
115201I1 | AAT Bioquest | 500 tests | EUR 918 |
PacBlue Anti-human CD152 Antibody *BN13* |
|||
115201J0 | AAT Bioquest | 100 tests | EUR 245 |
PacBlue Anti-human CD152 Antibody *BN13* |
|||
115201J1 | AAT Bioquest | 500 tests | EUR 918 |
PacOrange Anti-human CD152 Antibody *BN13* |
|||
115201K0 | AAT Bioquest | 100 tests | EUR 245 |
PacOrange Anti-human CD152 Antibody *BN13* |
|||
115201K1 | AAT Bioquest | 500 tests | EUR 918 |
PE Anti-human CD152 Antibody *BN13* |
|||
115201L0 | AAT Bioquest | 25 tests | EUR 179 |
PE Anti-human CD152 Antibody *BN13* |
|||
115201L1 | AAT Bioquest | 100 tests | EUR 505 |
PE Anti-human CD152 Antibody *BN13* |
|||
115201L2 | AAT Bioquest | 500 tests | EUR 1887 |
PerCP Anti-human CD152 Antibody *BN13* |
|||
115201T0 | AAT Bioquest | 25 tests | EUR 179 |
PerCP Anti-human CD152 Antibody *BN13* |
|||
115201T1 | AAT Bioquest | 100 tests | EUR 505 |
PerCP Anti-human CD152 Antibody *BN13* |
|||
115201T2 | AAT Bioquest | 500 tests | EUR 1887 |
Anti-Hu CD152 Purified |
|||
11-785-C025 | ExBio | 0.025 mg | EUR 118.8 |
Anti-Hu CD152 Purified |
|||
11-785-C100 | ExBio | 0.1 mg | EUR 189.6 |
Anti-Hu CD152 APC |
|||
1A-785-T100 | ExBio | 100 tests | EUR 288 |
Anti-Hu CD152 PE |
|||
1P-785-T025 | ExBio | 25 tests | EUR 168 |
Anti-Hu CD152 PE |
|||
1P-785-T100 | ExBio | 100 tests | EUR 288 |
Cytotoxic T-Lymphocyte Protein 4 (CD152) Antibody |
|||
abx139385-01mg | Abbexa | 0.1 mg | EUR 427.2 |
Cytotoxic T-Lymphocyte Protein 4 (CD152) Antibody |
|||
abx139386-01mg | Abbexa | 0.1 mg | EUR 427.2 |
Cytotoxic T-Lymphocyte Protein 4 (CD152) Antibody |
|||
20-abx133970 | Abbexa |
|
|
Cytotoxic T-Lymphocyte Protein 4 (CD152) Antibody |
|||
20-abx200703 | Abbexa |
|
|
Cytotoxic T-Lymphocyte Protein 4 (CD152) Antibody |
|||
20-abx225129 | Abbexa |
|
|
Cytotoxic T-Lymphocyte Protein 4 (CD152) Antibody |
|||
abx413284-02mg | Abbexa | 0.2 mg | EUR 811.2 |
Cytotoxic T-Lymphocyte Protein 4 (CD152) Antibody |
|||
abx413702-025mg | Abbexa | 0.25 mg | EUR 678 |
Cytotoxic T-Lymphocyte Protein 4 (CD152) Antibody |
|||
abx414772-025mg | Abbexa | 0.25 mg | EUR 678 |
Cytotoxic T-Lymphocyte Protein 4 (CD152) Antibody |
|||
abx414773-05mg | Abbexa | 0.5 mg | EUR 994.8 |
Cytotoxic T-Lymphocyte Protein 4 (CD152) Antibody |
|||
abx414774-01mg | Abbexa | 0.1 mg | EUR 526.8 |
Mouse Anti Human Cd152 Monoclonal Antibody,RPE |
|||
CABT-47107MH | Creative Diagnostics | 100 TEST | EUR 1008 |
APC/Cy7 Anti-human CD152 Antibody *BN13* |
|||
115201D0 | AAT Bioquest | 25 tests | EUR 210 |
APC/Cy7 Anti-human CD152 Antibody *BN13* |
|||
115201D1 | AAT Bioquest | 100 tests | EUR 587 |
APC/Cy7 Anti-human CD152 Antibody *BN13* |
|||
115201D2 | AAT Bioquest | 500 tests | EUR 1989 |
PE/Cy5 Anti-human CD152 Antibody *BN13* |
|||
115201M0 | AAT Bioquest | 25 tests | EUR 210 |
PE/Cy5 Anti-human CD152 Antibody *BN13* |
|||
115201M1 | AAT Bioquest | 100 tests | EUR 587 |
PE/Cy5 Anti-human CD152 Antibody *BN13* |
|||
115201M2 | AAT Bioquest | 500 tests | EUR 1989 |
PE/Cy7 Anti-human CD152 Antibody *BN13* |
|||
115201N0 | AAT Bioquest | 25 tests | EUR 210 |
PE/Cy7 Anti-human CD152 Antibody *BN13* |
|||
115201N1 | AAT Bioquest | 100 tests | EUR 587 |
PE/Cy7 Anti-human CD152 Antibody *BN13* |
|||
115201N2 | AAT Bioquest | 500 tests | EUR 1989 |
PerCP/Cy5.5 Anti-human CD152 Antibody *BN13* |
|||
115201U0 | AAT Bioquest | 25 tests | EUR 210 |
PerCP/Cy5.5 Anti-human CD152 Antibody *BN13* |
|||
115201U1 | AAT Bioquest | 100 tests | EUR 587 |
PerCP/Cy5.5 Anti-human CD152 Antibody *BN13* |
|||
115201U2 | AAT Bioquest | 500 tests | EUR 1989 |
CD152 [CTLA-4] Recombinant Protein |
|||
90-411 | ProSci | 100 ug | EUR 342.6 |
Description: CD152 and CD28, together with their ligands B7-1 and B7-2, constitute one of the dominant costimulatory pathways that regulate T and B cell responses. CD152 and CD28 are structurally homologous molecules that are members of the immunoglobulin (Ig) gene superfamily. Both CD152 and CD28 are composed of a single Ig V-like extracellular domain, a transmembrane domain and an intracellular domain. CD152 and CD28 are both expressed on the cell surface as disulfide-linked homodimers or as monomers. CD152 was originally identified as a gene that was specifically expressed by cytotoxic T lymphocytes. However, CD152 transcripts have since been found in both Th1 and Th2, and CD4+ and CD8+ T cell clones. Whereas, CD28 expression is constitutive on the surfaces of 95% of CD4+ T cells and 50% of CD8+ T cells and is down regulated upon T cell activation, CD152 expression is upregulated rapidly following T cell activation and peaks approximately 24 hours following activation. Although both CD152 and CD28 can bind to the same ligands, CD152 binds to B71 and B72 with 20-100-fold higher affinity than CD28. |
CD152 [CTLA-4] Recombinant Protein |
|||
90-412 | ProSci | 500 ug | EUR 556.8 |
Description: CD152 and CD28, together with their ligands B7-1 and B7-2, constitute one of the dominant costimulatory pathways that regulate T and B cell responses. CD152 and CD28 are structurally homologous molecules that are members of the immunoglobulin (Ig) gene superfamily. Both CD152 and CD28 are composed of a single Ig V-like extracellular domain, a transmembrane domain and an intracellular domain. CD152 and CD28 are both expressed on the cell surface as disulfide-linked homodimers or as monomers. CD152 was originally identified as a gene that was specifically expressed by cytotoxic T lymphocytes. However, CD152 transcripts have since been found in both Th1 and Th2, and CD4+ and CD8+ T cell clones. Whereas, CD28 expression is constitutive on the surfaces of 95% of CD4+ T cells and 50% of CD8+ T cells and is down regulated upon T cell activation, CD152 expression is upregulated rapidly following T cell activation and peaks approximately 24 hours following activation. Although both CD152 and CD28 can bind to the same ligands, CD152 binds to B71 and B72 with 20-100-fold higher affinity than CD28. |
CD152 [CTLA-4] Recombinant Protein |
|||
90-415 | ProSci | 100 ug | EUR 437.1 |
Description: CD152 [CTLA-4] and CD28, together with their ligands B7-1 and B7-2, constitute one of the dominant costimulatory pathways that regulate T and B cell responses. CD152 and CD28 are structurally homologous molecules that are members of the immunoglobulin (Ig) gene superfamily. Both CD152 and CD28 are composed of a single Ig V-like extracellular domain, a transmembrane domain and an intracellular domain. CD152 and CD28 are both expressed on the cell surface as disulfide-linked homodimers or as monomers. CD152 was originally identified as a gene that was specifically expressed by cytotoxic T lymphocytes. However, CD152 transcripts have since been found in both Th1 and Th2, and CD4 + and CD8 + T cell clones. Whereas, CD28 expression is constitutive on the surfaces of 95% of CD4 + T cells and 50% of CD8 + T cells and is down regulated upon T cell activation, CD152 expression is upregulated rapidly following T cell activation and peaks approximately 24 hours following activation. Although both CD152 and CD28 can bind to the same ligands, CD152 binds to B71 and B72 with 20-100-fold higher affinity than CD28. |
CD152 [CTLA-4] Recombinant Protein |
|||
90-416 | ProSci | 100 ug | EUR 374.1 |
Description: CD152 and CD28, together with their ligands B7-1 and B7-2, constitute one of the dominant costimulatory pathways that regulate T and B cell responses. CD152 and CD28 are structurally homologous molecules that are members of the immunoglobulin (Ig) gene superfamily. Both CD152 and CD28 are composed of a single Ig V-like extracellular domain, a transmembrane domain and an intracellular domain. CD152 and CD28 are both expressed on the cell surface as disulfide-linked homodimers or as monomers. CD152 was originally identified as a gene that was specifically expressed by cytotoxic T lymphocytes. However, CD152 transcripts have since been found in both Th1 and Th2, and CD4+ and CD8+ T cell clones. Whereas, CD28 expression is constitutive on the surfaces of 95% of CD4+ T cells and 50% of CD8+ T cells and is down regulated upon T cell activation, CD152 expression is upregulated rapidly following T cell activation and peaks approximately 24 hours following activation. Although both CD152 and CD28 can bind to the same ligands, CD152 binds to B71 and B72 with 20-100-fold higher affinity than CD28. |
CD152 [CTLA-4] Recombinant Protein |
|||
90-417 | ProSci | 500 ug | EUR 588.3 |
Description: CD152 and CD28, together with their ligands B7-1 and B7-2, constitute one of the dominant costimulatory pathways that regulate T and B cell responses. CD152 and CD28 are structurally homologous molecules that are members of the immunoglobulin (Ig) gene superfamily. Both CD152 and CD28 are composed of a single Ig V-like extracellular domain, a transmembrane domain and an intracellular domain. CD152 and CD28 are both expressed on the cell surface as disulfide-linked homodimers or as monomers. CD152 was originally identified as a gene that was specifically expressed by cytotoxic T lymphocytes. However, CD152 transcripts have since been found in both Th1 and Th2, and CD4+ and CD8+ T cell clones. Whereas, CD28 expression is constitutive on the surfaces of 95% of CD4+ T cells and 50% of CD8+ T cells and is down regulated upon T cell activation, CD152 expression is upregulated rapidly following T cell activation and peaks approximately 24 hours following activation. Although both CD152 and CD28 can bind to the same ligands, CD152 binds to B71 and B72 with 20-100-fold higher affinity than CD28. |
Anti-Hu CD152 Alexa Fluor647 |
|||
A6-785-T100 | ExBio | 100 tests | EUR 322.8 |
CTLA4 /CD152 (Human) ELISA Kit |
|||
K4157-100 | Biovision | EUR 992.4 |
Anti-Hu CD152 PE-Cy7 |
|||
T7-785-T100 | ExBio | 100 tests | EUR 321.6 |
Anti-Hu CD152 PE-Cy5 |
|||
T8-785-T100 | ExBio | 100 tests | EUR 288 |
Cytotoxic T-Lymphocyte Protein 4 (CD152) Antibody (PE) |
|||
abx139387-100tests | Abbexa | 100 tests | EUR 577.2 |
Cytotoxic T-Lymphocyte Protein 4 (CD152) Antibody (PE) |
|||
abx133969-100Assays | Abbexa | 100 Assays | EUR 594 |
Cytotoxic T-Lymphocyte Protein 4 (CD152) Antibody (PE) |
|||
abx133969-50Assays | Abbexa | 50 Assays | EUR 477.6 |
Cytotoxic T-Lymphocyte Protein 4 (CD152) Antibody (APC) |
|||
20-abx200696 | Abbexa |
|
|
Cytotoxic T-Lymphocyte Protein 4 (CD152) Antibody (PerCP) |
|||
20-abx200701 | Abbexa |
|
|
Cytotoxic T-Lymphocyte Protein 4 (CD152) Antibody (RPE) |
|||
abx413285-100tests2ml | Abbexa | 100 tests (2 ml) | EUR 710.4 |
Cytotoxic T-Lymphocyte Protein 4 (CD152) Antibody (RPE) |
|||
abx413286-25tests | Abbexa | 25 tests | EUR 376.8 |
Anti-CD152/ CTLA-4 Antibody [BNI3], Unconjugated-100ug |
|||
QAB59-100ug | EnQuireBio | 100ug | EUR 240 |
Anti-CD152/ CTLA-4 Antibody [BNI3], APC-100Tests |
|||
QAB59-APC-100Tests | EnQuireBio | 100Tests | EUR 422.4 |
Anti-CD152/ CTLA-4 Antibody [BNI3], APC-25Tests |
|||
QAB59-APC-25Tests | EnQuireBio | 25Tests | EUR 188.4 |
Anti-CD152/ CTLA-4 Antibody [BNI3], PE-100Tests |
|||
QAB59-PE-100Tests | EnQuireBio | 100Tests | EUR 310.8 |
Anti-CD152/ CTLA-4 Antibody [BNI3], PE-25Tests |
|||
QAB59-PE-25Tests | EnQuireBio | 25Tests | EUR 178.8 |
iFluor® 350 Anti-human CD152 Antibody *BN13* |
|||
11520010 | AAT Bioquest | 100 tests | EUR 245 |
iFluor® 350 Anti-human CD152 Antibody *BN13* |
|||
11520011 | AAT Bioquest | 500 tests | EUR 918 |
iFluor® 405 Anti-human CD152 Antibody *BN13* |
|||
11520020 | AAT Bioquest | 100 tests | EUR 245 |
iFluor® 405 Anti-human CD152 Antibody *BN13* |
|||
11520021 | AAT Bioquest | 500 tests | EUR 918 |
iFluor® 430 Anti-human CD152 Antibody *BN13* |
|||
11520030 | AAT Bioquest | 100 tests | EUR 245 |
iFluor® 430 Anti-human CD152 Antibody *BN13* |
|||
11520031 | AAT Bioquest | 500 tests | EUR 918 |
iFluor® 450 Anti-human CD152 Antibody *BN13* |
|||
11520040 | AAT Bioquest | 100 tests | EUR 245 |
iFluor® 450 Anti-human CD152 Antibody *BN13* |
|||
11520041 | AAT Bioquest | 500 tests | EUR 918 |
iFluor® 488 Anti-human CD152 Antibody *BN13* |
|||
11520050 | AAT Bioquest | 100 tests | EUR 245 |
iFluor® 488 Anti-human CD152 Antibody *BN13* |
|||
11520051 | AAT Bioquest | 500 tests | EUR 918 |